BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 132604)

  • 1. Binding of digoxigenin to sodium- and potassium-dependent adenosine triphosphatase.
    Yoda A
    Mol Pharmacol; 1976 May; 12(3):399-408. PubMed ID: 132604
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression by sodium, potassium or nucleotides of binding between cardiac steroid (digoxigenin) and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1979 Jul; 16(1):120-34. PubMed ID: 225651
    [No Abstract]   [Full Text] [Related]  

  • 3. Tritiated digoxin binding to (Na+ + K+)-activated adenosine triphosphatase: possible allosteric site.
    Schwartz A; Matsui H; Laughter AH
    Science; 1968 Apr; 160(3825):323-5. PubMed ID: 4230510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association and dissociation rate constants of the complexes between various cardiac aglycones and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1977 Mar; 13(2):352-61. PubMed ID: 140301
    [No Abstract]   [Full Text] [Related]  

  • 5. Sodium- and potassium-dependent adenosine triphosphatase of electric organ: interaction with ouabain in situ, in a membrane fraction, and in the solubilized form.
    Zubler-Faivre L; Dunant Y
    Mol Pharmacol; 1976 Nov; 12(6):1007-18. PubMed ID: 137360
    [No Abstract]   [Full Text] [Related]  

  • 6. Ouabain binding to sodium- and potassium-dependent adenosine triphosphatase: inhibition by the , -methylene analogue of adenosine triphosphate.
    Tobin T; Akera T; Hogg RE; Brody TM
    Mol Pharmacol; 1973 Mar; 9(2):278-81. PubMed ID: 4268124
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. II. Effects of sodium-activated transphosphorylation.
    Banerjee SP; Wong SM; Sen AK
    Mol Pharmacol; 1972 Jan; 8(1):18-29. PubMed ID: 4258646
    [No Abstract]   [Full Text] [Related]  

  • 8. The nature of the cardiac glycoside enzyme complex: mechanism and kinetics of binding and dissociation using a high-activity heart Na+, K+-ATPase.
    Schwartz A; Lindenmayer GE; Allen JC; McCans JL
    Ann N Y Acad Sci; 1974; 242(0):577-97. PubMed ID: 4279607
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible involvement of cardiac Na+, K+-adenosine triphosphatase in the mechanism of action of cardiac glycosides.
    Schwartz A; Allen JC; Harigaya S
    J Pharmacol Exp Ther; 1969 Jul; 168(1):31-41. PubMed ID: 4240030
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of pH on the interaction of cardiotonic steroids with sodium- and potasssium-dependent adenosine triphosphatase.
    Yoda A; Yoda S
    Mol Pharmacol; 1978 Jul; 14(4):624-32. PubMed ID: 28472
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.
    Albers RW; Koval GJ; Siegel
    Mol Pharmacol; 1968 Jul; 4(4):324-36. PubMed ID: 4232893
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mg-dependent adenosine triphosphatase activity of frog rectus abdominis muscle sarcolemma].
    Esyrev OV; Nikitin BN; Omarova RD
    Tsitologiia; 1972 Aug; 14(8):1050-3. PubMed ID: 4264118
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. I. Effects on sodium-sensitive phosphorylation and potassium-sensitive dephosphorylation.
    Banerjee SP; Wong SM; Khanna VK; Sen AK
    Mol Pharmacol; 1972 Jan; 8(1):8-17. PubMed ID: 4258649
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane adenosine triphosphatase. The effect of potassium on the formation and dissociation of the ouabain-enzyme complex.
    Akera T; Brody TM
    J Pharmacol Exp Ther; 1971 Mar; 176(3):545-57. PubMed ID: 4255765
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of phospholipids in the binding of ouabain to sodium- and potassium-dependent adenosine triphosphatase.
    Taniguchi K; Iida S
    Mol Pharmacol; 1973 May; 9(3):350-9. PubMed ID: 4267958
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the characterization of the sodium-potassium transport adenosine triphosphatase. 8. Effects of ligands on fluorescence due to interaction of the enzyme with a fluorescent derivative of hellebrigenin.
    Yoda A; Hokin LE
    Mol Pharmacol; 1972 Jan; 8(1):30-40. PubMed ID: 4258647
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of monovalent cations and Ca2+ on G-strophanthin binding to (Na+ plus K+)-activated ATPase.
    Hansen O
    Ann N Y Acad Sci; 1974; 242(0):635-45. PubMed ID: 4279611
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes.
    Yoda A; Yoda S; Sarrif AM
    Mol Pharmacol; 1973 Nov; 9(6):766-73. PubMed ID: 4271632
    [No Abstract]   [Full Text] [Related]  

  • 19. Relation between digitalis binding in vivo and inhibition of sodium, potassium-adenosine triphosphatase in canine kidney.
    Allen JC; Martinez-Maldonado M; Eknoyan G; Suki WN; Schwartz A
    Biochem Pharmacol; 1971 Jan; 20(1):73-80. PubMed ID: 4255110
    [No Abstract]   [Full Text] [Related]  

  • 20. Thermodynamics of the rate of binding of oubain to the sodium, potassium-adenosine triphosphatase.
    Wallick ET; Schwartz A
    J Biol Chem; 1974 Aug; 249(16):5141-7. PubMed ID: 4277738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.